Long term efficacy and safety of rivaroxaban plus cilostazol in the treatment of critical ischemia of the lower limbs in a frail, elderly patient with non valvular atrial fibrillation

Long term efficacy and safety of rivaroxaban plus cilostazol in the treatment of critical ischemia of the lower limbs in a frail, elderly patient with non valvular atrial fibrillation

Abstract Background Many patients with critical lower limb ischemia are not eligible for revascularization procedures. Still, given the emerging role of both platelet and coagulation activation in the formation of arterial thrombi, they may benefit from the novel anticoagulant and antiplatelet drugs...

Full description

Bibliographic Details
Main Authors: Antonio Trani, Pietro Benedetto, Ferdinando Di Leo, Angela Baiano, Andrea Esposito, Danilo Menna, Arianna Allegretti, Pierluigi Antonino Cappiello, Domenico Dell’Edera
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
Cilostazol
Critical lower limb ischemia
Elderly
Non valvular atrial fibrillation
Rivaroxaban
Online Access:http://link.springer.com/article/10.1186/s40780-020-00173-9

Internet

http://link.springer.com/article/10.1186/s40780-020-00173-9

Similar Items